Jiangsu Simcere Pharmaceutical Co,. Ltd.

No.699-18, Xuanwu Avenue, Yaohua Street, Qixia District, Nanjing, 江苏省, China

Clinical Trials

7 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Phase 1

57.3%

Phase 2

18.7%

Phase 3

14.7%

Phase 4

9.3%

Trial Status Distribution

Active, not recruiting

6.7%

Completed

33.3%

Not yet recruiting

2.7%

Recruiting

20.0%

Terminated

5.3%

Unknown

32.0%

Clinical Trials

Trials sponsored by this organization (75)

A Study of SIM0689 in Adult Participants With Locally Advanced or Metastatic Solid Tumors

Phase 1

Recruiting

interventional

Jul 2026472 participants

A Phase I, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single Ascending Doses of SIM0811 Injection in Healthy Chinese Adult Participants

Phase 1

Recruiting

interventional

Jan 202672 participants

An Open-Label Drug Interaction Clinical Study to Evaluate Itraconazole, Rifampin, Midazolam and SIM0270 in Chinese Healthy Adult Participants

Phase 1

Recruiting

interventional

Jan 202660 participants

A Phase Ib/III Study of Suvemcitug Plus FTD/TPI in Participants With Refractory Metastatic Colorectal Cancer

Phase 3

Recruiting

interventional

Nov 2025464 participants

A Phase I Study of SIM0609 in Adult Participants With Locally Advanced/Metastatic Solid Tumors

Phase 1

Recruiting

interventional

Nov 2025232 participants

Page 1 of 10

Approvals

No approval data available

News

No news articles found

Back to Organizations

Jiangsu Simcere Pharmaceutical Co,. Ltd.

Overview

Trial Phase Distribution

Trial Status Distribution

Clinical Trials

Trials sponsored by this organization (75)

A Study of SIM0689 in Adult Participants With Locally Advanced or Metastatic Solid Tumors

SIM0613 in Participants With Advanced Solid Tumors

A Phase I Study of SIM0532 in Adult Participants With Advanced Solid Tumors

First in Human Study of SIM0610 in Solid Tumors

A Phase I, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single Ascending Doses of SIM0811 Injection in Healthy Chinese Adult Participants

An Open-Label Drug Interaction Clinical Study to Evaluate Itraconazole, Rifampin, Midazolam and SIM0270 in Chinese Healthy Adult Participants

A Phase Ib/III Study of Suvemcitug Plus FTD/TPI in Participants With Refractory Metastatic Colorectal Cancer

A Phase I Study of SIM0609 in Adult Participants With Locally Advanced/Metastatic Solid Tumors

Approvals

News